CMN1 Stock Chart & Stats
€7.10
-€0.09(-1.18%)
At close: 4:00 PM EDT
€7.10
-€0.09(-1.18%)
Day’s Range― - ―
52-Week Range€5.15 - €7.19
Previous CloseN/A
Volume0.00
Average Volume (3M)468.00
Market Cap
€1.90B
Enterprise Value€1.49B
Total Cash (Recent Filing)€44.70M
Total Debt (Recent Filing)€189.20M
Price to Earnings (P/E)49.3
Beta0.97
Next Earnings
Dec 15, 2026EPS Estimate
0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.12
Shares Outstanding272,126,800
10 Day Avg. Volume666
30 Day Avg. Volume468
Financial Highlights & Ratios
PEG Ratio1.11
Price to Book (P/B)4.06
Price to Sales (P/S)3.12
P/FCF Ratio-277.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€7.34Price Target Upside3.35% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)<0.01
Revenue Forecast (FY)€6.37M
Bulls Say, Bears Say
Bulls Say
Improved Profitability And MarginsImproved EBIT/EBITDA and net margins along with a 12.62% ROE indicate the company is extracting more profit from sales and capital. Sustained margin improvement supports internal funding for projects, enhances resilience to cost shocks, and underpins long‑term earnings quality.
Manageable Balance Sheet LeverageA 0.40 debt-to-equity and ~44% equity ratio point to conservative leverage and financial flexibility. This reduces refinancing risk, enables steady funding for multi‑year defense programs, and supports investment or working capital needs without immediate reliance on external capital.
Recurring Government Contracts And Aftermarket SalesBusiness model centers on multi‑year government contracts and installed‑base aftermarket demand (spares, maintenance, support). These recurring, mission‑critical revenue streams create predictable long‑term cash inflows and high customer stickiness versus one‑off commercial exposure.
Bears Say
Declining Revenue TrendA declining top line (-4.57%) reduces operational leverage and limits room to scale fixed costs. If sustained, slower revenue undermines reinvestment capacity, may compress long‑term growth, and forces greater reliance on margin improvements or cost control to sustain profits.
Severe Deterioration In Free Cash FlowA ~185% drop in free cash flow signals weakening cash generation despite reported earnings. Persistent FCF weakness raises funding risk for capex, working capital and dividends, potentially necessitating external financing or cutbacks that could impair long‑term competitiveness.
Revenue Exposed To Government Budget TimingHigh dependence on government procurement cycles makes revenues lumpy and sensitive to budget shifts and award timing. Structural exposure to public spending variability complicates forecasting, capacity planning and steady growth execution over multi‑year horizons.
Chemring News
CMN1 FAQ
What was Chemring’s price range in the past 12 months?
Chemring lowest stock price was €5.15 and its highest was €7.19 in the past 12 months.
What is Chemring’s market cap?
Chemring’s market cap is €1.90B.
When is Chemring’s upcoming earnings report date?
Chemring’s upcoming earnings report date is Dec 15, 2026 which is in 137 days.
How were Chemring’s earnings last quarter?
Chemring released its earnings results on Jun 02, 2026. The company reported €0.071 earnings per share for the quarter, the consensus estimate of €0.071 by €0.
Is Chemring overvalued?
According to Wall Street analysts Chemring’s price is currently Undervalued.
Does Chemring pay dividends?
Chemring does not currently pay dividends.
What is Chemring’s EPS estimate?
Chemring’s EPS estimate is 0.16.
How many shares outstanding does Chemring have?
Chemring has 272,126,800 shares outstanding.
What happened to Chemring’s price movement after its last earnings report?
Chemring reported an EPS of €0.071 in its last earnings report, expectations of €0.071. Following the earnings report the stock price went down -5.485%.
Which hedge fund is a major shareholder of Chemring?
Currently, no hedge funds are holding shares in DE:CMN1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Chemring Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€7.34 (3.35% Upside)
€7.34 (3.35% Upside)
Insider Transactions
Bought Shares
Worth £246.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
47.50%
12-Months-Change
Fundamentals
Return on Equity
1.31%
Trailing 12-Months
Asset Growth
20.26%
Trailing 12-Months
Company Description
Chemring
Chemring Group Plc engages in the manufacture of technology products and services for the aerospace, defense, and security markets. It operates through the following segments: Sensors & Information; and Countermeasures & Energetics. The Sensors & Information segments provides consulting and technology services to solve security-critical issues. The Countermeasures & Energetics segment comprises of development and manufacture of expendable countermeasures for air and sea platforms, cartridge and propellant actuated devices, pyrotechnic devices for satellite launch and deployment, missile components, propellants, separation sub-systems, actuators, and energetic materials. The company was founded on November 30, 1905 and is headquartered in Romsey, the United Kingdom.
CMN1 Stock 12 Month Forecast
Average Price Target
€7.34
▲(3.35% Upside)